Barclays PLC Reata Pharmaceuticals Inc Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023
BUY
$79.22 - $105.37 $4.93 Million - $6.56 Million
62,278 Added 371.68%
79,034 $8.06 Million
Q1 2023

May 04, 2023
BUY
$30.85 - $93.17 $27,333 - $82,548
886 Added 5.58%
16,756 $1.52 Million
Q4 2022

Feb 13, 2023
BUY
$22.15 - $42.11 $44,477 - $84,556
2,008 Added 14.49%
15,870 $603,000
Q3 2022

Nov 03, 2022
SELL
$19.41 - $36.49 $34,336 - $64,550
-1,769 Reduced 11.32%
13,862 $348,000
Q2 2022

Aug 12, 2022
SELL
$20.71 - $36.5 $275,008 - $484,683
-13,279 Reduced 45.93%
15,631 $475,000
Q1 2022

May 16, 2022
SELL
$24.12 - $39.6 $771,381 - $1.27 Million
-31,981 Reduced 52.52%
28,910 $948,000
Q4 2021

Feb 14, 2022
BUY
$25.61 - $110.96 $901,267 - $3.9 Million
35,192 Added 136.94%
60,891 $1.61 Million
Q3 2021

Nov 09, 2021
BUY
$100.0 - $143.02 $2.08 Million - $2.97 Million
20,801 Added 424.68%
25,699 $2.59 Million
Q2 2021

Aug 13, 2021
SELL
$78.27 - $151.29 $231,600 - $447,667
-2,959 Reduced 37.66%
4,898 $693,000
Q1 2021

May 13, 2021
BUY
$94.25 - $132.81 $548,158 - $772,422
5,816 Added 284.96%
7,857 $784,000
Q4 2020

Feb 11, 2021
SELL
$102.03 - $184.62 $30,813 - $55,755
-302 Reduced 12.89%
2,041 $252,000
Q3 2020

Nov 12, 2020
SELL
$93.53 - $163.34 $1.64 Million - $2.87 Million
-17,586 Reduced 88.24%
2,343 $229,000
Q2 2020

Aug 12, 2020
SELL
$126.3 - $176.56 $1.48 Million - $2.06 Million
-11,682 Reduced 36.96%
19,929 $3.11 Million
Q1 2020

May 13, 2020
SELL
$124.16 - $247.74 $346,903 - $692,185
-2,794 Reduced 8.12%
31,611 $4.56 Million
Q4 2019

Feb 10, 2020
BUY
$74.57 - $217.92 $1.83 Million - $5.34 Million
24,495 Added 247.17%
34,405 $7.03 Million
Q3 2019

Nov 14, 2019
SELL
$71.26 - $95.75 $218,198 - $293,186
-3,062 Reduced 23.6%
9,910 $796,000
Q2 2019

Aug 14, 2019
SELL
$77.72 - $94.35 $61,010 - $74,064
-785 Reduced 5.71%
12,972 $1.22 Million
Q1 2019

May 15, 2019
BUY
$51.9 - $101.79 $216,578 - $424,769
4,173 Added 43.54%
13,757 $1.18 Million
Q4 2018

Feb 14, 2019
BUY
$48.76 - $76.44 $122,436 - $191,940
2,511 Added 35.5%
9,584 $537,000
Q3 2018

Nov 14, 2018
BUY
$35.64 - $92.06 $210,454 - $543,614
5,905 Added 505.57%
7,073 $578,000
Q2 2018

Aug 14, 2018
SELL
$19.94 - $40.96 $60,777 - $124,846
-3,048 Reduced 72.3%
1,168 $41,000
Q1 2018

May 15, 2018
BUY
$20.0 - $30.19 $14,400 - $21,736
720 Added 20.59%
4,216 $87,000
Q4 2017

Feb 14, 2018
SELL
$22.39 - $33.27 $9,672 - $14,372
-432 Reduced 11.0%
3,496 $99,000
Q3 2017

Nov 14, 2017
BUY
$26.29 - $31.88 $103,267 - $125,224
3,928
3,928 $122,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email